ArticleBritish journal of clinical pharmacology2026

Time to accelerate rare disease research: AI-powered in silico trials, digital twin-driven RCTs and decision-grade real-world evidence.

Andrej Belančić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.